Antithrombotic treatment in patients with stroke and supracardiac atherosclerosis.

Dimitrios SagrisGeorgios GeorgiopoulosIoannis LeventisKonstantinos PaterasLesly A PearceEleni KorompokiKonstantinos MakaritsisKonstantinos VemmosHaralampos MilionisGeorge Ntaios

Published in: Neurology (2020)

This systematic review and meta-analysis showed that anticoagulant-assigned patients with stroke and supracardiac atherosclerosis were not at different risk of ischemic stroke recurrence and increased risk of major bleeding compared to antiplatelet-assigned patients.

Keyphrases

atrial fibrillation
end stage renal disease
cardiovascular disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
type diabetes